Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle, +200

The Lancet Oncology

OncologyHepatologyMedicineClinical TrialsPembrolizumab Versus Lenvatinib +8

A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff

Noriko Oza, Yuichiro Eguchi, Toshihiko Mizuta, +13

Journal of Gastroenterology

Interdisciplinary Medical StaffWeight ManagementFatty Liver DiseaseObesity PreventionObesity +15

Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016

Atsushi Masamune, Kazuhiro Kikuta, Shin Hamada, +160

Pancreatology

Pancreatic Fluid CollectionNationwide Epidemiological SurveyClinical EpidemiologyGastroenterologyPancreatic Surgery +6

Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation

Noriko Oza, Hiroshi Isoda, Toshiki Ono, +1

Hepatology Research

Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis

Jun Itakura, Masayuki Kurosaki, Hiroko Setoyama, +15

Journal of Gastroenterology

Liver FibrosisHepatologyViral HepatitisLiver PhysiologyHepatitis +11

Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees

Kenichiro Murayama, Michiaki Okada, Kenichi Tanaka, +16

Diagnostics

Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non‐alcoholic fatty liver disease, but not in females

Eriko Ishibashi, Yuichiro Eguchi, Takahisa Eguchi, +13

Journal of Gastroenterology and Hepatology

Eradication of hepatitis C virus by interferon improves whole‐body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C

Yasunori Kawaguchi, Toshihiko Mizuta, Noriko Oza, +6

Liver International

Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C

Toshihiko Mizuta, Yuichiro Eguchi, Yasunori Kawaguchi, +9

Journal of Gastroenterology

HepatologyHepatitis CViral HepatitisLiver PhysiologyDiabetes +9

Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non‐alcoholic fatty liver disease

Kenichi Tanaka, Hirokazu Takahashi, Hideyuki Hyogo, +8

Hepatology Research